tm logo
PROBUTYRATE
Live/Registered
SECTION 8-ACCEPTED

accepted

on 19 Dec 2024

Last Applicant/ Owned by

1370 Trancas Street, Suite 350

Napa

CA

94558

Serial Number

87302021 filed on 13th Jan 2017

Registration Number

5414187 registered on 27th Feb 2018

in the Principal Register

Correspondent Address

Kim R. Pearson

Kim R. Pearson

Summerville, SC 29483

United States

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

PROBUTYRATE

Dietary supplements; nutritional supplements; medical foods, namely, medical food supplements and dietetic food supplements, both containing short-chain fatty acids in single molecule form with a release agent that enhances solubility and absorption; nutritional ingredients, namely, a blend of nutrients, namely, short-chain fatty acids in single molecule form with a release agent that ensures solu Read More

Classification Information


Class [005]
Pharmaceutical Products


Dietary supplements; nutritional supplements; medical foods, namely, medical food supplements and dietetic food supplements, both containing short-chain fatty acids in single molecule form with a release agent that enhances solubility and absorption; nutritional ingredients, namely, a blend of nutrients, namely, short-chain fatty acids in single molecule form with a release agent that ensures solubility and absorption, that are an integral component of medicals foods, for short-chain fatty acid deficiencies in individuals with Autism Spectrum Disorder; nutraceuticals for use as dietary supplements and nutritional supplements; vitamin preparations and mineral preparations to mitigate short-chain fatty acid microbiome deficiencies in individuals with Autism Spectrum Disorder; dietary supplements for restoring health in individuals with diseases, disorders, nutritional deficiencies, and adverse health conditions; therapeutic agents for human medical, medicinal, and therapeutic purposes, namely, increasing butyric acid in the gastrointestinal tract; functional nutrients containing butyric acid and acetic acid to mitigate short- chain fatty acid gut microbiome deficiencies in individuals with Autism Spectrum Disorder; pharmaceutical preparations to mitigate short-chain fatty acid gut microbiome deficiencies in individuals with Autism Spectrum Disorder; specialty nutraceuticals for the dietary management of diseases, disorders, and nutritional deficiencies, namely, short-chain fatty acid gut microbiome deficiencies in individuals with Autism Spectrum Disorder and deficiencies of butyrate in the gastrointestinal tract


First Use Date in General

24th Jul 2017

First Use Date in Commerce

24th Jul 2017

Mark Details


Serial Number

No 87302021

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
19th Dec 2024NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
19th Dec 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED
19th Dec 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02th Apr 2024TEAS SECTION 8 RECEIVED
27th Feb 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
27th Feb 2018REGISTERED-PRINCIPAL REGISTER
25th Jan 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
24th Jan 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
13th Jan 2018STATEMENT OF USE PROCESSING COMPLETE
13th Jan 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL